Noninvasive Prenatal Testing Using Circulating DNA and RNA: Advances, Challenges, and Possibilities

Area of Science:

• Obstetrics and Gynecology
• Genetics
• Precision Medicine

Background:

• Sequencing of cell-free DNA has revolutionized prenatal screening, decreasing invasive diagnostic procedures.
• Preeclampsia and preterm birth remain significant challenges requiring emergency interventions.
• Noninvasive prenatal testing (NIPT) offers potential for enhanced, personalized obstetric care.

Purpose of the Study:

• To review advances, challenges, and future possibilities in noninvasive prenatal testing for proactive, personalized obstetric care.
• To explore the application of cell-free nucleic acids, metabolomics, proteomics, intact cells, and microbiome analysis in prenatal diagnostics.
• To discuss ethical considerations and future directions, including disease taxonomy and causal biological understanding.

Main Methods:

• Review of current literature on noninvasive prenatal testing technologies.
• Analysis of research utilizing cell-free nucleic acids, metabolomics, proteomics, intact cells, and microbiome data.
• Discussion of ethical implications and future research trajectories.

Main Results:

• Significant progress in NIPT using cell-free DNA has reduced the need for invasive genetic testing.
• Emerging research explores diverse biomarkers beyond nucleic acids for comprehensive prenatal assessment.
• Ethical challenges and the need for a shift from correlation to causation in biomarker interpretation are identified.

Conclusions:

• Noninvasive prenatal testing is expanding the scope of precision medicine in obstetrics.
• Future advancements aim to enable proactive management of prevalent obstetric syndromes like preeclampsia and preterm birth.
• Further research is needed to refine diagnostic accuracy, address ethical concerns, and establish biological causality for improved prenatal care.